glp-1 agonist and dpp-4 inhibitor The Role of Inhibitors in the Treatment Algorithm of Type 2 Diabetes Mellitus: When to Select, What to Expect GLP-1 receptor agonist versus DPP-4
Description
This treatment option is especially beneficial for individuals with prediabetes, insulin resistance, or metabolic syndrome

Retatrutide (triple agonist) If tirzepatide was a step forward, retatrutide is a leap

Monitor patients for depression, suicidal thoughts, or other unusual changes in mood
69705-5/asset/079012c9-a24f-4391-ba39-2f5d03668f6f/main.assets/gr1_lrg.jpg)
As insurance coverage expands and out-of-pocket costs fall, use of GLP-1 drugs is likely to increase further, especially for weight loss

Diabetologia (2016) 59:26674
